Fractyl Health

At Fractyl Health, we know the key to transforming metabolic health lies in the gut.? This is why, even with weight loss treatments, a healthy diet must be maintained for long-term success in keeping off weight and ensuring a healthy gut microbiome. As discontinuing GLP-1 usage continues to become more prevalent, it becomes even more important to address the other aspects of weight management. Nutrition plays a large role in this, as does regular exercise, but they must be achieved in ways that are sustainable for your lifestyle, and in partnership with a healthcare provider. In conjunction with treatment options that target the root cause of poor metabolic health and weight gain, a consistent and healthy diet is a practical and essential step towards sustainable weight maintenance. #Nutrition #NationalNutritionMonth #MetabolicHealth #WeightLoss #WeightManagement #Type2Diabetes #Obesity

Weight loss treatments are an important tool in addressing obesity, but sustainable success comes from a comprehensive approach. Combining obesity treatment with healthy nutrition and hydration can lead to better long-term outcomes. At Fractyl Health, we recognize that obesity is a complex condition requiring personalized, holistic care. By integrating science-backed treatments that target the root cause of the disease alongside appropriate nutrition and hydration recommended by a healthcare provider, people living with obesity can achieve meaningful and lasting weight management. Learn more about our scientific solutions: https://lnkd.in/e2JUk6nf #NutritionandHydrationWeek #HealthManagement #WeightLoss #WeightManagement #Type2Diabetes #Obesity

Extra-wide spectator seating. Bariatric ambulances. Oversized coffins. ?? With more than half of the world’s population expected to have obesity by 2050, this The Guardian article paints a sobering picture of how stadiums, hospitals, airlines and other industries are adapting to the global obesity emergency.? https://lnkd.in/d7VH9BQa? But what if we could change this trajectory by reversing obesity rather than accommodating it? We can imagine a world where all this is possible. The progress made with GLP-1 drugs has allowed one massive step in that direction. Our work at Fractyl Health aims to solve the problem by allowing people to live their lives at a lower weight – freely. ? #Obesity #HealthInnovation #AskAQuestionDay?#FractylForward

Did you know that #obesity disproportionately impacts women? Nearly 42% of adult women in the U.S. live with obesity, placing them at increased risk for conditions like #heartdisease, #diabetes, and certain #cancers. Raising awareness and advancing solutions are essential steps towards improving women’s health outcomes. Women are the foundation of families and communities, often juggling multiple roles as professionals, caregivers and leaders. Their health and well-being are crucial – not just for themselves, but for society overall. When women thrive, communities flourish. Research, advocacy, and access to effective treatments all play a role in addressing this public health crisis. At Fractyl, we’re breaking the pattern of obesity treatment by addressing the root cause of this disease, to help ensure that women have the support they need to take charge of their health. #FractylForward #IWD2025 #WomensHistoryMonth #ObesityAwareness #WomenInHealth

We’re breaking the pattern of #obesity and?#T2D. Read more about Fractyl Health’s (#NASDAQ: $GUTS) Q4 and Full Year 2024 financial results and our potentially novel approach to weight maintenance here: https://bit.ly/3F4RQnl Tune in now:?https://bit.ly/3D1KikB #FractylHealthNews #FractylForward

UPCOMING: We’re pleased to share our Q4 and full year 2024 #earnings on Monday, March 3, at 4:30 PM ET. ? Join us for the live webcast: https://bit.ly/3D1KikB ? #NASDAQ: $GUTS #FractylForward

Our Co-Founder & CEO, Harith Rajagopalan, is featured in the latest PharmaVoice Biotech Spotlight, diving into our #obesity pipeline and #T2D gene therapy.?We anticipate multiple readouts in 2025 that have the potential to shape the future of metabolic disease treatment. Explore the feature to see what’s ahead:?https://lnkd.in/g2ATgZyU #FractylForward

Participation in the REMAIN-1 pivotal study remains strong. Learn more about how we are targeting a root cause of obesity, and meeting the unmet need of weight maintenance, here: https://lnkd.in/e3kDQw52. *Revita is for investigational use only in the US under Federal law. #FractylForward #obesity?

Today, we announced we are prioritizing our REMAIN-1 study, addressing an unmet need for an off-ramp to GLP-1 drugs, while advancing our novel Rejuva gene therapy platform into first-in-human studies. Read more about the announcement: https://bit.ly/4hBa1ir $GUTS #FractylForward #ObesityData #Obesity

The Fractyl team had a fantastic week at #JPM25. We’re excited to build on this momentum as we advance our pipeline of novel therapies that target root causes of obesity and type 2 diabetes. Learn more about our approach here: https://lnkd.in/e67c-avY. ? #FractylForward #JPM25 #obesity